JP2022550316A5 - - Google Patents
Info
- Publication number
- JP2022550316A5 JP2022550316A5 JP2022518946A JP2022518946A JP2022550316A5 JP 2022550316 A5 JP2022550316 A5 JP 2022550316A5 JP 2022518946 A JP2022518946 A JP 2022518946A JP 2022518946 A JP2022518946 A JP 2022518946A JP 2022550316 A5 JP2022550316 A5 JP 2022550316A5
- Authority
- JP
- Japan
- Prior art keywords
- ehd2
- domain
- amino acid
- modified
- binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025014991A JP2025081354A (ja) | 2019-09-25 | 2025-01-31 | 修飾ehd2ドメインを含む結合モジュール |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19199639 | 2019-09-25 | ||
| EP19199639.6 | 2019-09-25 | ||
| PCT/EP2020/077008 WO2021058804A1 (en) | 2019-09-25 | 2020-09-25 | Binding modules comprising modified ehd2 domains |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025014991A Division JP2025081354A (ja) | 2019-09-25 | 2025-01-31 | 修飾ehd2ドメインを含む結合モジュール |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022550316A JP2022550316A (ja) | 2022-12-01 |
| JP2022550316A5 true JP2022550316A5 (cg-RX-API-DMAC7.html) | 2023-04-18 |
Family
ID=68109107
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022518946A Pending JP2022550316A (ja) | 2019-09-25 | 2020-09-25 | 修飾ehd2ドメインを含む結合モジュール |
| JP2025014991A Withdrawn JP2025081354A (ja) | 2019-09-25 | 2025-01-31 | 修飾ehd2ドメインを含む結合モジュール |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025014991A Withdrawn JP2025081354A (ja) | 2019-09-25 | 2025-01-31 | 修飾ehd2ドメインを含む結合モジュール |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220372147A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4034244A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2022550316A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220071210A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115066275A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020356407A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3155725A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022003507A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021058804A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4454706A1 (en) | 2023-04-24 | 2024-10-30 | Universität Stuttgart | Novel egfr binding proteins |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US7829084B2 (en) * | 2001-01-17 | 2010-11-09 | Trubion Pharmaceuticals, Inc. | Binding constructs and methods for use thereof |
| NZ592611A (en) * | 2008-10-10 | 2013-01-25 | Emergent Product Dev Seattle | A single chain fusion protein that binds to tcr complex and does not induce or induces a minimally detectable cytokine release |
| US20130089554A1 (en) * | 2009-12-29 | 2013-04-11 | Emergent Product Development Seattle, Llc | RON Binding Constructs and Methods of Use Thereof |
| JP6400470B2 (ja) * | 2011-05-16 | 2018-10-03 | ジェネロン(シャンハイ)コーポレイション リミテッド | 多重特異性Fab融合タンパク質および使用法 |
| WO2013075027A2 (en) * | 2011-11-17 | 2013-05-23 | Emergent Product Development Seattle, Llc | Anti-sil6xr complex binding domains and methods of use |
| WO2013156054A1 (en) * | 2012-04-16 | 2013-10-24 | Universität Stuttgart | The igm and ige heavy chain domain 2 as covalently linked homodimerization modules for the generation of fusion proteins with dual specificity |
| CA3096486C (en) * | 2014-11-14 | 2023-02-07 | The Procter & Gamble Company | Silicone compounds |
| WO2016146818A1 (en) * | 2015-03-18 | 2016-09-22 | Universität Stuttgart | Single-chain tnf ligand family molecules and fusion proteins and derivatives thereof |
| WO2017011342A1 (en) * | 2015-07-10 | 2017-01-19 | Abbvie Inc. | Igm-or-ige-modified binding proteins and uses thereof |
| WO2017106462A1 (en) * | 2015-12-18 | 2017-06-22 | Biogen Ma Inc. | Bispecific antibody platform |
| HUE065861T2 (hu) * | 2016-08-26 | 2024-06-28 | Sanofi Sa | Szelektív könnyûlánc-párosítást elõsegítõ multispecifikus antitestek |
| KR102469700B1 (ko) * | 2016-09-15 | 2022-11-23 | 우니베르지테트 스튜트가르트 | Her3에 대한 항원 결합 단백질 |
| WO2019179627A1 (en) * | 2018-03-22 | 2019-09-26 | Universität Stuttgart | Multivalent binding molecules |
| US20220396635A1 (en) * | 2019-09-25 | 2022-12-15 | Universität Stuttgart | Trivalent binding molecules |
| HUE062777T2 (hu) * | 2020-02-26 | 2023-12-28 | Vir Biotechnology Inc | SARS-CoV-2 elleni antitestek |
| US11192940B2 (en) * | 2020-04-10 | 2021-12-07 | Adagio Therapeutics, Inc. | Compounds specific to coronavirus S protein and uses thereof |
| WO2022082217A1 (en) * | 2020-10-16 | 2022-04-21 | Eureka Therapeutics, Inc. | Compositions for preventing or treating viral and other microbial infections |
-
2020
- 2020-09-25 EP EP20785700.4A patent/EP4034244A1/en active Pending
- 2020-09-25 AU AU2020356407A patent/AU2020356407A1/en active Pending
- 2020-09-25 US US17/762,463 patent/US20220372147A1/en not_active Abandoned
- 2020-09-25 CA CA3155725A patent/CA3155725A1/en active Pending
- 2020-09-25 MX MX2022003507A patent/MX2022003507A/es unknown
- 2020-09-25 JP JP2022518946A patent/JP2022550316A/ja active Pending
- 2020-09-25 WO PCT/EP2020/077008 patent/WO2021058804A1/en not_active Ceased
- 2020-09-25 CN CN202080082634.XA patent/CN115066275A/zh active Pending
- 2020-09-25 KR KR1020227012195A patent/KR20220071210A/ko active Pending
-
2025
- 2025-01-31 JP JP2025014991A patent/JP2025081354A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7001474B2 (ja) | 非免疫原性単一ドメイン抗体 | |
| Mochly-Rosen et al. | Monoclonal anti-acetylcholine-receptor antibodies directed against the cholinergic binding site | |
| JP2020022464A5 (cg-RX-API-DMAC7.html) | ||
| JP2023504914A5 (cg-RX-API-DMAC7.html) | ||
| JP2020500510A5 (cg-RX-API-DMAC7.html) | ||
| JP6009431B2 (ja) | アフィニティー精製の方法 | |
| JP2014518883A5 (cg-RX-API-DMAC7.html) | ||
| JP2024105229A5 (cg-RX-API-DMAC7.html) | ||
| DK2747782T3 (en) | Long-term inhibition of interleukin-6-mediated signal transmission | |
| CN109705213B (zh) | 抗金黄色葡萄球菌毒素抗体及其用途 | |
| US20220033481A1 (en) | Compositions and methods for increasing protein half-life in a serum | |
| JP2010501552A (ja) | 分配向上物質が接合された生物物質を使用した水性二相系抽出法での親和性分離方法 | |
| FR2974816A1 (fr) | Methode de generation de proteines | |
| CN105829889A (zh) | 用于测定多价、多特异性分子的生物活性的基于spr的桥接测定法 | |
| CN102703388A (zh) | 抗人mCRP蛋白的单克隆抗体、杂交瘤细胞系和试剂盒 | |
| JP2023553694A5 (cg-RX-API-DMAC7.html) | ||
| CN102746403A (zh) | 用于elisa检测黄曲霉毒素的标准品通用替代物、其制备方法及黄曲霉毒素elisa检测方法 | |
| Reese et al. | Purification of animal immunoglobulin G (IgG) using peptoid affinity ligands | |
| CN110878124B (zh) | Dna聚合酶的抗体片段、抗体及其应用 | |
| Xie et al. | Outperforming biorecognition: epitope-imprinted nanoparticle enables high-species-specificity purification of human IgG | |
| JP2024503425A5 (cg-RX-API-DMAC7.html) | ||
| Marchalonis et al. | Antigenic cross-reactions among immunoglobulin of diverse vertebrates (elasmobranchs to man) detected using xenoantisera | |
| KR20190134617A (ko) | Il-1r-i 결합 폴리펩티드 | |
| CN102321177A (zh) | 一种抗三聚氰胺单链抗体及其应用体 | |
| JP2004500055A5 (cg-RX-API-DMAC7.html) |